- Home
- / Kuur Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Kuur Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|
| Revenue | 106.0K | 24.0K | |
| Revenue growth, % | -77.4% | -100.0% | |
| General and administrative expense | 6.9M | 9.4M | 43.2M |
| Operating expense total | 20.7M | 25.9M | 55.7M |
| Depreciation and amortization | 332.0K | 546.0K | 616.0K |
| EBIT | (20.6M) | (25.7M) | (55.3M) |
| EBIT margin, % | -19410.4% | -107125.0% | |
| Interest income | 38.0K | 19.0K | 143.0K |
| Pre tax profit | (23.2M) | (36.3M) | (51.8M) |
| Income tax expense | (1.0M) | (6.4M) | (4.7M) |
| Net Income | (22.2M) | (29.9M) | (47.1M) |